FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

3771511000001100: Pro-Viron 25mg tablets (Schering Health Care Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17218701000001111 Pro-Viron 25mg tablets (Schering Health Care Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
44856801000001112 Pro-Viron 25mg tablets (Bayer Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pro-Viron 25mg tablets (Schering Health Care Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Pro-Viron 25mg tablets (Schering Health Care Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 4 (CD Anab) true Inferred relationship Existential restriction modifier
Pro-Viron 25mg tablets (Schering Health Care Ltd) Is a Product containing precisely mesterolone 25 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Pro-Viron 25mg tablets (Schering Health Care Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Pro-Viron 25mg tablets (Schering Health Care Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Pro-Viron 25mg tablets (Schering Health Care Ltd) Has excipient Paraben and/or paraben derivative false Inferred relationship Existential restriction modifier
Pro-Viron 25mg tablets (Schering Health Care Ltd) Has active ingredient Mesterolone false Inferred relationship Existential restriction modifier
Pro-Viron 25mg tablets (Schering Health Care Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Pro-Viron 25mg tablets (Schering Health Care Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Pro-Viron 25mg tablets (Schering Health Care Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Pro-Viron 25mg tablets (Schering Health Care Ltd) Is a Pro-Viron true Inferred relationship Existential restriction modifier
Pro-Viron 25mg tablets (Schering Health Care Ltd) Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Pro-Viron 25mg tablets (Schering Health Care Ltd) Has specific active ingredient Mesterolone true Inferred relationship Existential restriction modifier
Pro-Viron 25mg tablets (Schering Health Care Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Pro-Viron 25mg tablets (Schering Health Care Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Pro-Viron 25mg tablets (Schering Health Care Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Pro-Viron 25mg tablets (Schering Health Care Ltd) 30 tablet 3 x 10 tablets Is pack of False Pro-Viron 25mg tablets (Schering Health Care Ltd) Inferred relationship Existential restriction modifier
Pro-Viron 25mg tablets (Schering Health Care Ltd) 30 tablet 3 x 10 tablets Has AMP True Pro-Viron 25mg tablets (Schering Health Care Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start